Forward Pharma
Ulrich Mrowietz (Scientific Advisor)
Torsten Goesch (Director)
Kristian Reich (Scientific Advisor)
Summary
History
Forward Pharma was founded in 2000 with the mission of developing innovative therapies to improve the lives of patients suffering from autoimmune and inflammatory diseases. The company has been a pioneer in immunomodulation, leveraging its expertise to develop and commercialize two novel product candidates. In 2014, the company secured a worldwide licensing agreement with Genentech for the commercialization of its lead product candidate, FP187. This agreement provided the company with the resources to expand and accelerate its product pipeline and commercialization efforts.
Mission
Vision
Key Team
Florian Schonharting (Co-Founder & Chairman of the Board)
Duncan Moore (Independent Non-Executive Director)
Jerry S. Wolinsky (Scientific Advisor)
Per Soelberg Sørensen (Scientific Advisor)
Grant Hellier Lawrence (Independent Director)
Fred D. Lublin (Scientific Advisor)
Giancarlo Comi (Scientific Advisor)
Jakob Mosegaard Larsen (Director)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Ulrich Mrowietz (Scientific Advisor)
Torsten Goesch (Director)
Kristian Reich (Scientific Advisor)